Tetra Radar · Company Timeline

Incyte Corp (INCY)

Sector: Health Care

Earlier observations

  1. · FDA approval. The FDA approved JAKAFI XR for treatment of intermediate or high-risk myelofibrosis, including primary myelofibrosis, post-polycythemia vera myelofibrosis, and post-essential thrombocythemia myelofibrosis in adults, and other uses.

Observations from the last 30 days, with Clusters and Heat Signatures, are in the Tetra Radar Library.

Dates are event dates. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.